Category: Uncategorized

joimax® Launches Its Latest Interlaminar Endoscopic System, iLESSYS® Pro, and New 4K Camera Light Source and Documentation Command System, Camsource® LED and Vitegra® at AANS in New Orleans, LA and GSC in Singapore

Karlsruhe, Germany – May 1st 2018 – joimax® again launches new product innovations at the upcoming American Association of Neurological Surgeons (AANS) taking place in New Orleans from April 28 – May 2, and at the Global Spine Congress (GSC) in Singapore, starting May 2. The German based market leader of technologies and training methods
WEITERLESEN

joimax® Presents Its New Generation 4K Camera Light Source and Documentation Command System, Camsource® LED and Vitegra® at AAOS in New Orleans, LA

Karlsruhe, Germany – March 7th, 2018 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery presents its newest combined 4K resolution camera and LED light source system, Camsource® LED and its fully integrated documentation and command system, Vitegra® Docu and Command. Both systems are introduced for
WEITERLESEN

joimax® continues strong growth trend in 2017 with launch of its MultiZYTE® Facet and SI Joint treatment Set in the US and also obtains full approval of its Endovapor® 2 system in China

Karlsruhe, Germany – February 8, 2018 – the joimax® group announces very strong sales figures for 2017. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery shows a jump of almost 80% vs. 2016 in the U.S. Consolidated sales show a growth of nearly 30%, which reflects its
WEITERLESEN

Newly awarded German Growth Champion joimax® presents new products at DWG Stuttgart, Germany, and broadens its education and congress activities

IRVINE, CA – November 30, 2017 – joimax®, recently awarded as German Growth Champion 2018, continues to share its expertise in endoscopic minimally invasive spine surgery. With the latest workshops in Krasnodar, RUS, Guadalajara, Mexico and at the Wooridul Hospital in Korea, the company strengthens its outstanding education program. During the workshops, surgeons are trained
WEITERLESEN

joimax® reports another record in revenues globally in Q3/2017 and introduces new products at EUROSPINE in Dublin, Ireland and at NASS in Orlando, Florida

IRVINE, CA – October, 10, 2017 – Due to the fast growing user interest, but moreover the patient demand for endoscopic spinal surgery, joimax® sees another record in revenues in Q3/2017, with almost 60% of growth year over year, whereas joimax USA is almost doubling its revenues compared to 2016. “These results are also reflected
WEITERLESEN

joimax® , Inc. opens its first Education & Training Center in Irvine, California, posts record sales in the US and continues to make gains with endoscopic reimbursement

IRVINE, CA – August, 31, 2017– joimax® announces the grand opening of its new state-of-the-art Training and Education Center in Irvine, California. The company will be holding its first workshop at the Center on September 8-9th. As the market leader in endoscopic spine surgery, joimax® is fully dedicated to outstanding physician education, training and services
WEITERLESEN

joimax® elevates its presence across Europe and Asia

Irvine, CA – June 7, 2017 – Over the last few weeks, joimax® participated in numerous scientific meetings, held across Europe and Asia. During these meetings, the German-based company reiterated its position as market leader for endoscopic minimally invasive spine surgery. Starting in early May, joimax® exhibited at this years’ Global Spine Congress (GSC, http://www.gsc2017.org)
WEITERLESEN

joimax® announces 510(k) clearance for its Endovapor® 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System. The patented device generates electrical power for
WEITERLESEN